Evidence map›Paper›PMID 26919294›Full record

Observational studyPloS one2016

Molecular Identification and Echinocandin Susceptibility of Candida parapsilosis Complex Bloodstream Isolates in Italy, 2007-2014.

Grazia Lovero, Elisa Borghi, Stella Balbino, Daniela Cirasola, Osvalda De Giglio, Federica Perdoni, Giuseppina Caggiano, Giulia Morace, Maria Teresa Montagna

Abstract readComparative StudyObservational Study
In one paragraph

Observational study in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Heterogeneity ofMicrobiology spectrum · 2025
    Article
  4. Investigation of clonal relationship in hospital-associated Candida parapsilosis isolates.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
  5. Article
  6. Review
  7. Change in species distribution and antifungal susceptibility of candidemias in an intensive care unit of a university hospital (10-year experience).European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2021
    Article
  8. Identification of Cryptic Species of FourJournal of fungi (Basel, Switzerland) · 2019
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Grazia LoveroDepartment of Biomedical Science and Human Oncology, Hygiene Section, Università degli Studi of Bari "Aldo Moro", Bari, Italy.
Elisa BorghiDepartment of Health Sciences, Università degli Studi di Milano, Milan, Italy.
Stella BalbinoDepartment of Biomedical Science and Human Oncology, Hygiene Section, Università degli Studi of Bari "Aldo Moro", Bari, Italy.
Daniela CirasolaDepartment of Health Sciences, Università degli Studi di Milano, Milan, Italy.
Osvalda De GiglioDepartment of Biomedical Science and Human Oncology, Hygiene Section, Università degli Studi of Bari "Aldo Moro", Bari, Italy.
Federica PerdoniDepartment of Health Sciences, Università degli Studi di Milano, Milan, Italy.
Giuseppina CaggianoDepartment of Biomedical Science and Human Oncology, Hygiene Section, Università degli Studi of Bari "Aldo Moro", Bari, Italy.
Giulia MoraceDepartment of Health Sciences, Università degli Studi di Milano, Milan, Italy.
Maria Teresa MontagnaDepartment of Biomedical Science and Human Oncology, Hygiene Section, Università degli Studi of Bari "Aldo Moro", Bari, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Candida parapsilosis group encompasses three species: C. parapsilosis, C. orthopsilosis, and C. metapsilosis. Here, we describe the incidence and echinocandin susceptibility profile of bloodstream isolates of these three species collected from patients admitted to an Italian university hospital from 2007 to 2014. Molecular identification of cryptic species of the C. parapsilosis complex was performed using polymerase chain reaction amplification of the gene encoding secondary alcohol dehydrogenase, followed by digestion with the restriction enzyme BanI. Minimum inhibitory concentrations were determined using the broth microdilution method according to European Committee for Antimicrobial Susceptibility Testing (EUCAST EDef 7.2) and Clinical Laboratory Standards Institute (CLSI M27-A3) guidelines, and the results were compared with those obtained using the E-test and Sensititre methods. Of the 163 C. parapsilosis complex isolates, 136 (83.4%) were identified as C. parapsilosis, and 27 (16.6%) as C. orthopsilosis. The species-specific incidences were 2.9/10,000 admissions for C. parapsilosis and 0.6/10,000 admissions for C. orthopsilosis. No resistance to echinocandins was detected with any of the methods. The percent essential agreement (EA) between the EUCAST and E-test/Sensititre methods for anidulafungin, caspofungin, and micafungin susceptibility was, respectively, as follows: C. parapsilosis, 95.6/97.8, 98.5/88.2, and 93.4/96.3; C. orthopsilosis, 92.6/92.6, 96.3/77.8, and 63.0/66.7. The EA between the CLSI and E-test/Sensititre methods was, respectively, as follows: C. parapsilosis, 99.3/100, 98.5/89.0, and 96.3/98.5; C. orthopsilosis, 96.3/92.6, 100/81.5, and 92.6/88.9. Only minor discrepancies, ranging from 16.9% (C. parapsilosis) to 11.1% (C. orthopsilosis), were observed between the CLSI and E-test/Sensititre methods. In conclusion, this epidemiologic study shows a typical C. parapsilosis complex species distribution, no echinocandin resistance, and it reinforces the relevance of using commercially available microbiological methods to assess antifungal susceptibility. These data improve our knowledge of the national distribution of species of the psilosis group, as there are very few studies of these species in Italy.

Indexed as

Alcohol OxidoreductasesAntifungal AgentsCandidaCandidemiaCross InfectionDeoxyribonucleases, Type II Site-SpecificEchinocandinsFungal ProteinsGenes, FungalHospitals, UniversityHumansItalyMicrobial Sensitivity TestsPolymerase Chain ReactionPolymorphism, Restriction Fragment LengthProspective StudiesAlcohol OxidoreductasesAntifungal AgentsDeoxyribonucleases, Type II Site-SpecificEchinocandinsendodeoxyribonuclease BanIFungal Proteinsisopropanol dehydrogenase (NADP)

Identifiers

PMID26919294
PMCPMC4769087

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.